カテゴリー： 世界, 医療/バイオ, QYResearch

多糖類止血システムの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Polysaccharide Hemostatic System Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09994）・商品コード：QY22JLX09994
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、多糖類止血システムのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に多糖類止血システムの世界市場のxxx％を占める「薬局システム」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
多糖類止血システムの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの多糖類止血システム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

多糖類止血システムのグローバル主要企業には、Starch Medical、Medical Expo、Medical Devices Business Services、CryoLife、EndoClot Plus、Baxter、Celox、Equimedical、Medira、Biocer、Hemostasisなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

多糖類止血システム市場は、種類と用途によって区分されます。世界の多糖類止血システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
薬局システム、機器システム

【用途別セグメント】
病院、クリニック、外来手術センター、外科センター、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 多糖類止血システム製品概要
- 種類別市場（薬局システム、機器システム）
- 用途別市場（病院、クリニック、外来手術センター、外科センター、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の多糖類止血システム販売量予測2017-2028
- 世界の多糖類止血システム売上予測2017-2028
- 多糖類止血システムの地域別販売量
- 多糖類止血システムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別多糖類止血システム販売量
- 主要メーカー別多糖類止血システム売上
- 主要メーカー別多糖類止血システム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（薬局システム、機器システム）
- 多糖類止血システムの種類別販売量
- 多糖類止血システムの種類別売上
- 多糖類止血システムの種類別価格
・用途別市場規模（病院、クリニック、外来手術センター、外科センター、その他）
- 多糖類止血システムの用途別販売量
- 多糖類止血システムの用途別売上
- 多糖類止血システムの用途別価格
・北米市場
- 北米の多糖類止血システム市場規模（種類別、用途別）
- 主要国別の多糖類止血システム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの多糖類止血システム市場規模（種類別、用途別）
- 主要国別の多糖類止血システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の多糖類止血システム市場規模（種類別、用途別）
- 主要国別の多糖類止血システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の多糖類止血システム市場規模（種類別、用途別）
- 主要国別の多糖類止血システム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの多糖類止血システム市場規模（種類別、用途別）
- 主要国別の多糖類止血システム市場規模（トルコ、サウジアラビア）
・企業情報
Starch Medical、Medical Expo、Medical Devices Business Services、CryoLife、EndoClot Plus、Baxter、Celox、Equimedical、Medira、Biocer、Hemostasis
・産業チェーン及び販売チャネル分析
- 多糖類止血システムの産業チェーン分析
- 多糖類止血システムの原材料
- 多糖類止血システムの生産プロセス
- 多糖類止血システムの販売及びマーケティング
- 多糖類止血システムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 多糖類止血システムの産業動向
- 多糖類止血システムのマーケットドライバー
- 多糖類止血システムの課題
- 多糖類止血システムの阻害要因
・主な調査結果

Market Analysis and Insights: Global Polysaccharide Hemostatic System Market
Due to the COVID-19 pandemic, the global Polysaccharide Hemostatic System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Pharmacy System accounting for % of the Polysaccharide Hemostatic System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Polysaccharide Hemostatic System market size is valued at US$ million in 2021, while the US and Europe Polysaccharide Hemostatic System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Polysaccharide Hemostatic System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Polysaccharide Hemostatic System include Starch Medical, Medical Expo, Medical Devices Business Services, CryoLife, EndoClot Plus, Baxter, Celox, Equimedical and Medira, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Polysaccharide Hemostatic System Scope and Segment
Polysaccharide Hemostatic System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Polysaccharide Hemostatic System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pharmacy System
Instrument System
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Surgery Centers
Others
By Company
Starch Medical
Medical Expo
Medical Devices Business Services
CryoLife
EndoClot Plus
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Polysaccharide Hemostatic System Product Introduction
1.2 Market by Type
1.2.1 Global Polysaccharide Hemostatic System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmacy System
1.2.3 Instrument System
1.3 Market by Application
1.3.1 Global Polysaccharide Hemostatic System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Surgery Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polysaccharide Hemostatic System Sales Estimates and Forecasts 2017-2028
2.2 Global Polysaccharide Hemostatic System Revenue Estimates and Forecasts 2017-2028
2.3 Global Polysaccharide Hemostatic System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Polysaccharide Hemostatic System Sales by Region
2.4.1 Global Polysaccharide Hemostatic System Sales by Region (2017-2022)
2.4.2 Global Sales Polysaccharide Hemostatic System by Region (2023-2028)
2.5 Global Polysaccharide Hemostatic System Revenue by Region
2.5.1 Global Polysaccharide Hemostatic System Revenue by Region (2017-2022)
2.5.2 Global Polysaccharide Hemostatic System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Polysaccharide Hemostatic System Sales by Manufacturers
3.1.1 Global Top Polysaccharide Hemostatic System Manufacturers by Sales (2017-2022)
3.1.2 Global Polysaccharide Hemostatic System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polysaccharide Hemostatic System in 2021
3.2 Global Polysaccharide Hemostatic System Revenue by Manufacturers
3.2.1 Global Polysaccharide Hemostatic System Revenue by Manufacturers (2017-2022)
3.2.2 Global Polysaccharide Hemostatic System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Polysaccharide Hemostatic System Revenue in 2021
3.3 Global Polysaccharide Hemostatic System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Polysaccharide Hemostatic System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Polysaccharide Hemostatic System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polysaccharide Hemostatic System Sales by Type
4.1.1 Global Polysaccharide Hemostatic System Historical Sales by Type (2017-2022)
4.1.2 Global Polysaccharide Hemostatic System Forecasted Sales by Type (2023-2028)
4.1.3 Global Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
4.2 Global Polysaccharide Hemostatic System Revenue by Type
4.2.1 Global Polysaccharide Hemostatic System Historical Revenue by Type (2017-2022)
4.2.2 Global Polysaccharide Hemostatic System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
4.3 Global Polysaccharide Hemostatic System Price by Type
4.3.1 Global Polysaccharide Hemostatic System Price by Type (2017-2022)
4.3.2 Global Polysaccharide Hemostatic System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Polysaccharide Hemostatic System Sales by Application
5.1.1 Global Polysaccharide Hemostatic System Historical Sales by Application (2017-2022)
5.1.2 Global Polysaccharide Hemostatic System Forecasted Sales by Application (2023-2028)
5.1.3 Global Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
5.2 Global Polysaccharide Hemostatic System Revenue by Application
5.2.1 Global Polysaccharide Hemostatic System Historical Revenue by Application (2017-2022)
5.2.2 Global Polysaccharide Hemostatic System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
5.3 Global Polysaccharide Hemostatic System Price by Application
5.3.1 Global Polysaccharide Hemostatic System Price by Application (2017-2022)
5.3.2 Global Polysaccharide Hemostatic System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Polysaccharide Hemostatic System Market Size by Type
6.1.1 North America Polysaccharide Hemostatic System Sales by Type (2017-2028)
6.1.2 North America Polysaccharide Hemostatic System Revenue by Type (2017-2028)
6.2 North America Polysaccharide Hemostatic System Market Size by Application
6.2.1 North America Polysaccharide Hemostatic System Sales by Application (2017-2028)
6.2.2 North America Polysaccharide Hemostatic System Revenue by Application (2017-2028)
6.3 North America Polysaccharide Hemostatic System Market Size by Country
6.3.1 North America Polysaccharide Hemostatic System Sales by Country (2017-2028)
6.3.2 North America Polysaccharide Hemostatic System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Polysaccharide Hemostatic System Market Size by Type
7.1.1 Europe Polysaccharide Hemostatic System Sales by Type (2017-2028)
7.1.2 Europe Polysaccharide Hemostatic System Revenue by Type (2017-2028)
7.2 Europe Polysaccharide Hemostatic System Market Size by Application
7.2.1 Europe Polysaccharide Hemostatic System Sales by Application (2017-2028)
7.2.2 Europe Polysaccharide Hemostatic System Revenue by Application (2017-2028)
7.3 Europe Polysaccharide Hemostatic System Market Size by Country
7.3.1 Europe Polysaccharide Hemostatic System Sales by Country (2017-2028)
7.3.2 Europe Polysaccharide Hemostatic System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Polysaccharide Hemostatic System Market Size by Type
8.1.1 Asia Pacific Polysaccharide Hemostatic System Sales by Type (2017-2028)
8.1.2 Asia Pacific Polysaccharide Hemostatic System Revenue by Type (2017-2028)
8.2 Asia Pacific Polysaccharide Hemostatic System Market Size by Application
8.2.1 Asia Pacific Polysaccharide Hemostatic System Sales by Application (2017-2028)
8.2.2 Asia Pacific Polysaccharide Hemostatic System Revenue by Application (2017-2028)
8.3 Asia Pacific Polysaccharide Hemostatic System Market Size by Region
8.3.1 Asia Pacific Polysaccharide Hemostatic System Sales by Region (2017-2028)
8.3.2 Asia Pacific Polysaccharide Hemostatic System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Polysaccharide Hemostatic System Market Size by Type
9.1.1 Latin America Polysaccharide Hemostatic System Sales by Type (2017-2028)
9.1.2 Latin America Polysaccharide Hemostatic System Revenue by Type (2017-2028)
9.2 Latin America Polysaccharide Hemostatic System Market Size by Application
9.2.1 Latin America Polysaccharide Hemostatic System Sales by Application (2017-2028)
9.2.2 Latin America Polysaccharide Hemostatic System Revenue by Application (2017-2028)
9.3 Latin America Polysaccharide Hemostatic System Market Size by Country
9.3.1 Latin America Polysaccharide Hemostatic System Sales by Country (2017-2028)
9.3.2 Latin America Polysaccharide Hemostatic System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Polysaccharide Hemostatic System Market Size by Type
10.1.1 Middle East and Africa Polysaccharide Hemostatic System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Polysaccharide Hemostatic System Revenue by Type (2017-2028)
10.2 Middle East and Africa Polysaccharide Hemostatic System Market Size by Application
10.2.1 Middle East and Africa Polysaccharide Hemostatic System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Polysaccharide Hemostatic System Revenue by Application (2017-2028)
10.3 Middle East and Africa Polysaccharide Hemostatic System Market Size by Country
10.3.1 Middle East and Africa Polysaccharide Hemostatic System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Polysaccharide Hemostatic System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Starch Medical
11.1.1 Starch Medical Corporation Information
11.1.2 Starch Medical Overview
11.1.3 Starch Medical Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Starch Medical Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Starch Medical Recent Developments
11.2 Medical Expo
11.2.1 Medical Expo Corporation Information
11.2.2 Medical Expo Overview
11.2.3 Medical Expo Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medical Expo Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medical Expo Recent Developments
11.3 Medical Devices Business Services
11.3.1 Medical Devices Business Services Corporation Information
11.3.2 Medical Devices Business Services Overview
11.3.3 Medical Devices Business Services Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medical Devices Business Services Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medical Devices Business Services Recent Developments
11.4 CryoLife
11.4.1 CryoLife Corporation Information
11.4.2 CryoLife Overview
11.4.3 CryoLife Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CryoLife Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CryoLife Recent Developments
11.5 EndoClot Plus
11.5.1 EndoClot Plus Corporation Information
11.5.2 EndoClot Plus Overview
11.5.3 EndoClot Plus Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 EndoClot Plus Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 EndoClot Plus Recent Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Overview
11.6.3 Baxter Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Recent Developments
11.7 Celox
11.7.1 Celox Corporation Information
11.7.2 Celox Overview
11.7.3 Celox Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Celox Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Celox Recent Developments
11.8 Equimedical
11.8.1 Equimedical Corporation Information
11.8.2 Equimedical Overview
11.8.3 Equimedical Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Equimedical Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Equimedical Recent Developments
11.9 Medira
11.9.1 Medira Corporation Information
11.9.2 Medira Overview
11.9.3 Medira Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Medira Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Medira Recent Developments
11.10 Biocer
11.10.1 Biocer Corporation Information
11.10.2 Biocer Overview
11.10.3 Biocer Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Biocer Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Biocer Recent Developments
11.11 Hemostasis
11.11.1 Hemostasis Corporation Information
11.11.2 Hemostasis Overview
11.11.3 Hemostasis Polysaccharide Hemostatic System Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hemostasis Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hemostasis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polysaccharide Hemostatic System Industry Chain Analysis
12.2 Polysaccharide Hemostatic System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polysaccharide Hemostatic System Production Mode & Process
12.4 Polysaccharide Hemostatic System Sales and Marketing
12.4.1 Polysaccharide Hemostatic System Sales Channels
12.4.2 Polysaccharide Hemostatic System Distributors
12.5 Polysaccharide Hemostatic System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Polysaccharide Hemostatic System Industry Trends
13.2 Polysaccharide Hemostatic System Market Drivers
13.3 Polysaccharide Hemostatic System Market Challenges
13.4 Polysaccharide Hemostatic System Market Restraints
14 Key Findings in The Global Polysaccharide Hemostatic System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Polysaccharide Hemostatic System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pharmacy System
Table 3. Major Manufacturers of Instrument System
Table 4. Global Polysaccharide Hemostatic System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Polysaccharide Hemostatic System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Polysaccharide Hemostatic System Sales by Region (2017-2022) & (K Units)
Table 7. Global Polysaccharide Hemostatic System Sales Market Share by Region (2017-2022)
Table 8. Global Polysaccharide Hemostatic System Sales by Region (2023-2028) & (K Units)
Table 9. Global Polysaccharide Hemostatic System Sales Market Share by Region (2023-2028)
Table 10. Global Polysaccharide Hemostatic System Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Polysaccharide Hemostatic System Revenue Market Share by Region (2017-2022)
Table 12. Global Polysaccharide Hemostatic System Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Polysaccharide Hemostatic System Revenue Market Share by Region (2023-2028)
Table 14. Global Polysaccharide Hemostatic System Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Polysaccharide Hemostatic System Sales Share by Manufacturers (2017-2022)
Table 16. Global Polysaccharide Hemostatic System Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Polysaccharide Hemostatic System Revenue Share by Manufacturers (2017-2022)
Table 18. Polysaccharide Hemostatic System Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Polysaccharide Hemostatic System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Polysaccharide Hemostatic System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic System as of 2021)
Table 21. Polysaccharide Hemostatic System Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Polysaccharide Hemostatic System Product Offered
Table 23. Date of Manufacturers Enter into Polysaccharide Hemostatic System Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Polysaccharide Hemostatic System Sales by Type (2017-2022) & (K Units)
Table 26. Global Polysaccharide Hemostatic System Sales by Type (2023-2028) & (K Units)
Table 27. Global Polysaccharide Hemostatic System Sales Share by Type (2017-2022)
Table 28. Global Polysaccharide Hemostatic System Sales Share by Type (2023-2028)
Table 29. Global Polysaccharide Hemostatic System Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Polysaccharide Hemostatic System Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Polysaccharide Hemostatic System Revenue Share by Type (2017-2022)
Table 32. Global Polysaccharide Hemostatic System Revenue Share by Type (2023-2028)
Table 33. Polysaccharide Hemostatic System Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Polysaccharide Hemostatic System Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Polysaccharide Hemostatic System Sales by Application (2017-2022) & (K Units)
Table 36. Global Polysaccharide Hemostatic System Sales by Application (2023-2028) & (K Units)
Table 37. Global Polysaccharide Hemostatic System Sales Share by Application (2017-2022)
Table 38. Global Polysaccharide Hemostatic System Sales Share by Application (2023-2028)
Table 39. Global Polysaccharide Hemostatic System Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Polysaccharide Hemostatic System Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Polysaccharide Hemostatic System Revenue Share by Application (2017-2022)
Table 42. Global Polysaccharide Hemostatic System Revenue Share by Application (2023-2028)
Table 43. Polysaccharide Hemostatic System Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Polysaccharide Hemostatic System Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Polysaccharide Hemostatic System Sales by Type (2017-2022) & (K Units)
Table 46. North America Polysaccharide Hemostatic System Sales by Type (2023-2028) & (K Units)
Table 47. North America Polysaccharide Hemostatic System Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Polysaccharide Hemostatic System Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Polysaccharide Hemostatic System Sales by Application (2017-2022) & (K Units)
Table 50. North America Polysaccharide Hemostatic System Sales by Application (2023-2028) & (K Units)
Table 51. North America Polysaccharide Hemostatic System Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Polysaccharide Hemostatic System Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Polysaccharide Hemostatic System Sales by Country (2017-2022) & (K Units)
Table 54. North America Polysaccharide Hemostatic System Sales by Country (2023-2028) & (K Units)
Table 55. North America Polysaccharide Hemostatic System Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Polysaccharide Hemostatic System Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Polysaccharide Hemostatic System Sales by Type (2017-2022) & (K Units)
Table 58. Europe Polysaccharide Hemostatic System Sales by Type (2023-2028) & (K Units)
Table 59. Europe Polysaccharide Hemostatic System Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Polysaccharide Hemostatic System Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Polysaccharide Hemostatic System Sales by Application (2017-2022) & (K Units)
Table 62. Europe Polysaccharide Hemostatic System Sales by Application (2023-2028) & (K Units)
Table 63. Europe Polysaccharide Hemostatic System Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Polysaccharide Hemostatic System Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Polysaccharide Hemostatic System Sales by Country (2017-2022) & (K Units)
Table 66. Europe Polysaccharide Hemostatic System Sales by Country (2023-2028) & (K Units)
Table 67. Europe Polysaccharide Hemostatic System Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Polysaccharide Hemostatic System Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Polysaccharide Hemostatic System Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Polysaccharide Hemostatic System Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Polysaccharide Hemostatic System Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Polysaccharide Hemostatic System Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Polysaccharide Hemostatic System Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Polysaccharide Hemostatic System Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Polysaccharide Hemostatic System Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Polysaccharide Hemostatic System Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Polysaccharide Hemostatic System Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Polysaccharide Hemostatic System Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Polysaccharide Hemostatic System Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Polysaccharide Hemostatic System Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Polysaccharide Hemostatic System Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Polysaccharide Hemostatic System Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Polysaccharide Hemostatic System Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Polysaccharide Hemostatic System Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Polysaccharide Hemostatic System Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Polysaccharide Hemostatic System Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Polysaccharide Hemostatic System Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Polysaccharide Hemostatic System Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Polysaccharide Hemostatic System Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Polysaccharide Hemostatic System Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Polysaccharide Hemostatic System Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Polysaccharide Hemostatic System Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Polysaccharide Hemostatic System Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Polysaccharide Hemostatic System Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Polysaccharide Hemostatic System Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Polysaccharide Hemostatic System Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Polysaccharide Hemostatic System Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Polysaccharide Hemostatic System Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Polysaccharide Hemostatic System Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Polysaccharide Hemostatic System Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Polysaccharide Hemostatic System Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Polysaccharide Hemostatic System Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Polysaccharide Hemostatic System Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Polysaccharide Hemostatic System Revenue by Country (2023-2028) & (US$ Million)
Table 105. Starch Medical Corporation Information
Table 106. Starch Medical Description and Major Businesses
Table 107. Starch Medical Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Starch Medical Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Starch Medical Recent Developments
Table 110. Medical Expo Corporation Information
Table 111. Medical Expo Description and Major Businesses
Table 112. Medical Expo Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Medical Expo Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Medical Expo Recent Developments
Table 115. Medical Devices Business Services Corporation Information
Table 116. Medical Devices Business Services Description and Major Businesses
Table 117. Medical Devices Business Services Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Medical Devices Business Services Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Medical Devices Business Services Recent Developments
Table 120. CryoLife Corporation Information
Table 121. CryoLife Description and Major Businesses
Table 122. CryoLife Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. CryoLife Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. CryoLife Recent Developments
Table 125. EndoClot Plus Corporation Information
Table 126. EndoClot Plus Description and Major Businesses
Table 127. EndoClot Plus Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. EndoClot Plus Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. EndoClot Plus Recent Developments
Table 130. Baxter Corporation Information
Table 131. Baxter Description and Major Businesses
Table 132. Baxter Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Baxter Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Baxter Recent Developments
Table 135. Celox Corporation Information
Table 136. Celox Description and Major Businesses
Table 137. Celox Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Celox Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Celox Recent Developments
Table 140. Equimedical Corporation Information
Table 141. Equimedical Description and Major Businesses
Table 142. Equimedical Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Equimedical Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Equimedical Recent Developments
Table 145. Medira Corporation Information
Table 146. Medira Description and Major Businesses
Table 147. Medira Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Medira Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Medira Recent Developments
Table 150. Biocer Corporation Information
Table 151. Biocer Description and Major Businesses
Table 152. Biocer Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Biocer Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Biocer Recent Developments
Table 155. Hemostasis Corporation Information
Table 156. Hemostasis Description and Major Businesses
Table 157. Hemostasis Polysaccharide Hemostatic System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Hemostasis Polysaccharide Hemostatic System Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Hemostasis Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Polysaccharide Hemostatic System Distributors List
Table 163. Polysaccharide Hemostatic System Customers List
Table 164. Polysaccharide Hemostatic System Market Trends
Table 165. Polysaccharide Hemostatic System Market Drivers
Table 166. Polysaccharide Hemostatic System Market Challenges
Table 167. Polysaccharide Hemostatic System Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Polysaccharide Hemostatic System Product Picture
Figure 3. Global Polysaccharide Hemostatic System Market Share by Type in 2021 & 2028
Figure 3. Pharmacy System Product Picture
Figure 4. Instrument System Product Picture
Figure 5. Global Polysaccharide Hemostatic System Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Ambulatory Surgical Centers
Figure 9. Surgery Centers
Figure 10. Others
Figure 11. Polysaccharide Hemostatic System Report Years Considered
Figure 12. Global Polysaccharide Hemostatic System Sales 2017-2028 (K Units)
Figure 13. Global Polysaccharide Hemostatic System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Polysaccharide Hemostatic System Revenue 2017-2028 (US$ Million)
Figure 15. Global Polysaccharide Hemostatic System Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Polysaccharide Hemostatic System Sales Market Share by Region (2017-2022)
Figure 17. Global Polysaccharide Hemostatic System Sales Market Share by Region (2023-2028)
Figure 18. North America Polysaccharide Hemostatic System Sales YoY (2017-2028) & (K Units)
Figure 19. North America Polysaccharide Hemostatic System Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Polysaccharide Hemostatic System Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Polysaccharide Hemostatic System Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Polysaccharide Hemostatic System Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Polysaccharide Hemostatic System Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Polysaccharide Hemostatic System Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Polysaccharide Hemostatic System Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Polysaccharide Hemostatic System Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Polysaccharide Hemostatic System Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Polysaccharide Hemostatic System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Polysaccharide Hemostatic System in the World: Market Share by Polysaccharide Hemostatic System Revenue in 2021
Figure 30. Global Polysaccharide Hemostatic System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
Figure 32. Global Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
Figure 33. Global Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
Figure 34. Global Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
Figure 35. North America Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
Figure 36. North America Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
Figure 37. North America Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
Figure 38. North America Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
Figure 39. North America Polysaccharide Hemostatic System Sales Share by Country (2017-2028)
Figure 40. North America Polysaccharide Hemostatic System Revenue Share by Country (2017-2028)
Figure 41. United States Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
Figure 44. Europe Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
Figure 45. Europe Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
Figure 46. Europe Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
Figure 47. Europe Polysaccharide Hemostatic System Sales Share by Country (2017-2028)
Figure 48. Europe Polysaccharide Hemostatic System Revenue Share by Country (2017-2028)
Figure 49. Germany Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 50. France Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Polysaccharide Hemostatic System Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Polysaccharide Hemostatic System Revenue Share by Region (2017-2028)
Figure 60. China Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 63. India Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
Figure 70. Latin America Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
Figure 72. Latin America Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Polysaccharide Hemostatic System Sales Share by Country (2017-2028)
Figure 74. Latin America Polysaccharide Hemostatic System Revenue Share by Country (2017-2028)
Figure 75. Mexico Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Polysaccharide Hemostatic System Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Polysaccharide Hemostatic System Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Polysaccharide Hemostatic System Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Polysaccharide Hemostatic System Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Polysaccharide Hemostatic System Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Polysaccharide Hemostatic System Revenue Share by Country (2017-2028)
Figure 84. Turkey Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Polysaccharide Hemostatic System Revenue (2017-2028) & (US$ Million)
Figure 87. Polysaccharide Hemostatic System Value Chain
Figure 88. Polysaccharide Hemostatic System Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


★調査レポート[多糖類止血システムの世界市場インサイト・予測（～2028年）] (コード：QY22JLX09994)販売に関する免責事項を必ずご確認ください。
★調査レポート[多糖類止血システムの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 微孔性多糖ヘモスフィア（MPH）の世界市場インサイト・予測（～2028年）
  • 超音波止血ナイフの世界市場インサイト・予測（～2028年）
  • 吸収性止血材の世界市場インサイト・予測（～2028年）
  • 髄膜炎菌多糖類ワクチンの世界市場インサイト・予測（～2028年）
  • タマリンド多糖類ガムの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆